Stock DLTN.F DELTA 9 CANNABIS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Delta 9 Cannabis Inc. OTC Markets

Equities

DLTN.F

CA2477541049

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 20:11:33 15/07/2024 BST 		5-day change 1st Jan Change
0.00755 USD +7.86% Intraday chart for Delta 9 Cannabis Inc. -14.61% -62.93%
07-15 FIKA entered into a binding term sheet agreement to acquire Cannabis retail store business and the logistics and distribution business of Delta 9 Cannabis Inc. (TSX:DN). CI
07-08 SNDL Completes Purchase of Delta 9 Cannabis Debt MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 104.5 61.57 52.04 30.6 8.95 5.304
Enterprise Value (EV) 1 93.75 84.65 79.74 66.41 71.62 67.8
P/E ratio -11.7 x 4.67 x -7.11 x -2.64 x -0.27 x -0.25 x
Yield - - - - - -
Capitalization / Revenue 13.8 x 1.94 x 1 x 0.49 x 0.14 x 0.07 x
EV / Revenue 12.4 x 2.66 x 1.53 x 1.07 x 1.13 x 0.95 x
EV / EBITDA -12.4 x 152 x 53.7 x -25.8 x -4.94 x -9.1 x
EV / FCF -4.12 x -3.26 x -17.7 x -30.8 x 136 x 18.7 x
FCF Yield -24.3% -30.6% -5.66% -3.25% 0.74% 5.35%
Price to Book 2.94 x 1.79 x 1.62 x 1.24 x 1.37 x -0.73 x
Nbr of stocks (in thousands) 85,686 87,963 102,039 105,515 149,166 212,167
Reference price 2 1.220 0.7000 0.5100 0.2900 0.0600 0.0250
Announcement Date 22/04/19 19/03/20 31/03/21 31/03/22 31/03/23 01/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 7.569 31.77 52.05 62.29 63.23 71.07
EBITDA 1 -7.558 0.5575 1.484 -2.574 -14.49 -7.449
EBIT 1 -8.501 -2.2 -2.71 -7.639 -20.18 -13.49
Operating Margin -112.31% -6.92% -5.21% -12.26% -31.92% -18.99%
Earnings before Tax (EBT) 1 -8.585 13.52 -5.084 -11.54 -27.84 -16.64
Net income 1 -8.486 13.74 -6.418 -11.18 -27.2 -17.52
Net margin -112.11% 43.27% -12.33% -17.94% -43.02% -24.65%
EPS 2 -0.1044 0.1500 -0.0718 -0.1100 -0.2200 -0.1000
Free Cash Flow 1 -22.74 -25.94 -4.51 -2.156 0.5268 3.625
FCF margin -300.47% -81.67% -8.67% -3.46% 0.83% 5.1%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 22/04/19 19/03/20 31/03/21 31/03/22 31/03/23 01/04/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 12.48 17.5 15.69 17.56 16.9 18.25 18.44
EBITDA 1 - -0.391 -1.683 -1.48 -0.4756 1.362 1.031
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income - - - - - - -
Net margin - - - - - - -
EPS - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 16/05/22 15/08/22 15/11/22 01/04/23 15/05/23 14/08/23 14/11/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 23.1 27.7 35.8 62.7 62.5
Net Cash position 1 10.8 - - - - -
Leverage (Debt/EBITDA) - 41.39 x 18.66 x -13.91 x -4.325 x -8.39 x
Free Cash Flow 1 -22.7 -25.9 -4.51 -2.16 0.53 3.63
ROE (net income / shareholders' equity) -28.7% 38.8% -17.1% -38.3% -175% -29,674%
ROA (Net income/ Total Assets) -14.9% -2.45% -2.43% -6.32% -15.1% -10.3%
Assets 1 56.77 -560.5 263.8 177 180.7 169.9
Book Value Per Share 2 0.4100 0.3900 0.3100 0.2300 0.0400 -0.0300
Cash Flow per Share 2 0.1900 0.0700 0.0800 0.0100 0.0200 0.0100
Capex 1 16.8 14 5.84 2.58 2.36 0.65
Capex / Sales 221.86% 44.18% 11.22% 4.14% 3.74% 0.92%
Announcement Date 22/04/19 19/03/20 31/03/21 31/03/22 31/03/23 01/04/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+61.53% 856B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.95% 631B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.66% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.06% 325B
ABBVIE INC. Stock AbbVie Inc.
+9.18% 297B
ROCHE HOLDING AG Stock Roche Holding AG
+5.89% 234B
NOVARTIS AG Stock Novartis AG
+16.53% 226B
AMGEN INC. Stock Amgen Inc.
+15.67% 177B
PFIZER, INC. Stock Pfizer, Inc.
+2.47% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. DN Stock
  4. DLTN.F Stock
  5. Financials Delta 9 Cannabis Inc.